Congresswoman Miller questions big pharma executives about research investments at House hearing

Former Celgene CEO Mark Alles explains to West Virginia Congresswoman Carol Miller at a House Oversight and Reform Committee at the first of two hearings with pharmaceutical executives that in the last year before Bristol Myers Squibb acquired the company his regulation was research and development and spend 37 percent of its revenue, Teva CEO Kare Schultz answering his company spent a proximally 1 billion dollars each year, Bristol Myers Squibb CEO Giovanni Caforio explaining research and development was one of the highest in the industry on many programs that would ultimately not work including long and expensive clinical development programs and brain cancer, lung cancer, promote state cancer and other diseases that it failed, so the need to obtain a return on research and development investment was an important factor in thinking about the price of medicine.
Former Celgene CEO Mark Alles explains to West Virginia Congresswoman Carol Miller at a House Oversight and Reform Committee at the first of two hearings with pharmaceutical executives that in the last year before Bristol Myers Squibb acquired the company his regulation was research and development and spend 37 percent of its revenue, Teva CEO Kare Schultz answering his company spent a proximally 1 billion dollars each year, Bristol Myers Squibb CEO Giovanni Caforio explaining research and development was one of the highest in the industry on many programs that would ultimately not work including long and expensive clinical development programs and brain cancer, lung cancer, promote state cancer and other diseases that it failed, so the need to obtain a return on research and development investment was an important factor in thinking about the price of medicine.
購買授權

請告訴我們您希望何時、何地及如何使用此資產，以獲得個人化價格。

詳情

限制條件：
May not be used as partisan political campaign material to promote or oppose the candidacy of any person for elective public office, and may not be used to distort the objects and purposes of the hearing, or cast discredit on or dishonor any member of the U.S. House of Representatives or U.S. Senate, or bring the House or Senate or any Member into disrepute.
來源:
FedNet / Getty Images
編輯性內容編號：
1278031645
圖像集:
FedNet
建立日期：
2020年09月30日
上傳日期：
授權類型：
權利準備 (Rights-Ready)
發佈資訊:
無許可授權 更多資料
短片長度：
00:01:18:02
位置:
Washington, DC, United States
原版：
QuickTime 8-bit H.264 HD 1280x720 30p
來源：
FedNet
物件名稱：
hov093020k